Caitlin Guinn
Family · Phoenix, AZNPI 1265064539
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.1% of the total across 567 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 37 manufacturers, the largest accounting for just 14.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $3,883 and has fallen 61.1% since, to $1,511 in 2023. Among family clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 567 payments — averaging $15.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Biohaven Pharmaceuticals, Inc.$919
- Novo Nordisk$832
- AstraZeneca$793
- Boehringer Ingelheim$571
- Otsuka America Pharmaceutical, Inc.$519
- plus $4K from 31 others
What the payments were for
- Consulting fees$8009%
- Food & beverage$8,19691%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 125 | $1,259 |
| Biohaven Pharmaceuticals, Inc. | 9 | $919 |
| Novo Nordisk | 61 | $832 |
| AstraZeneca | 29 | $793 |
| Boehringer Ingelheim | 32 | $571 |
| Otsuka America Pharmaceutical, Inc. | 15 | $519 |
| Takeda Pharmaceuticals U.S.A., Inc. | 42 | $468 |
| Lilly USA, LLC | 43 | $356 |
| Amgen | 28 | $326 |
| Abbott | 18 | $293 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $292 |
| Bayer | 16 | $288 |
| Sanofi-aventis U.S. LLC | 14 | $243 |
| Amarin Pharma, Inc. | 14 | $196 |
| Novartis | 13 | $195 |
| Biohaven Pharmaceutical Holding Company Ltd. | 10 | $194 |
| GSK | 15 | $159 |
| Daiichi Sankyo Inc. | 8 | $146 |
| Esperion Therapeutics, Inc. | 9 | $141 |
| Kowa Pharmaceuticals America, Inc. | 9 | $139 |
| Eisai Inc. | 9 | $132 |
| Merck | 6 | $103 |
| Fidia Pharma USA Inc. | 4 | $66 |
| Paratek Pharmaceuticals, Inc. | 4 | $62 |
| Johnson & Johnson | 4 | $55 |
| Idorsia Pharmaceuticals US Inc | 3 | $51 |
| Antares Pharma, Inc. | 2 | $42 |
| Kyowa Kirin, Inc. | 1 | $28 |
| Alfasigma USA, Inc. | 1 | $20 |
| Boston Scientific | 1 | $19 |
| Corcept Therapeutics | 1 | $17 |
| Pfizer | 1 | $17 |
| Mycovia Pharmaceuticals, Inc. | 1 | $15 |
| Mylan Specialty L.p. | 1 | $13 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Endo Pharmaceuticals Inc. | 1 | $11 |
| Genentech USA, Inc. | 1 | $6 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$8,996 in reported general payments places this provider in the 95th percentile of 4,119 family providers in Arizona.
Other family in Phoenix
- Kimberly HallaPhoenix$332K
- Audrey StevensonPhoenix$83K
- Rebekah EdwardsPhoenix$51K
- Tirsa QuartulloPhoenix$31K
- Jessica AcostaPhoenix$30K
- Stephanie JohnstonPhoenix$25K
- Kelly MarcelloPhoenix$23K
- Judith BergmanPhoenix$22K
- Lauren BonnerPhoenix$22K
- Rita GonzalezPhoenix$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.